Patents by Inventor Nathalie Engel

Nathalie Engel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6924106
    Abstract: The present invention primarily relates to a DNA fragment which is obtainable from the gene cluster responsible for rifamycin biosynthesis within the genome of Amycolatopsis mediterranei, and comprises at least one gene or a part of a gene which codes for a polypeptide which is directly or indirectly involved in the biosynthesis of rifamycin, and to a method for preparing said DNA fragment. The present invention furthermore relates to recombinant DNA molecules which comprise one of the DNA fragments according to the invention, and to the plasmids and vectors derived therefrom. Host organisms transformed with said plasmid or vector DNA are likewise embraced.
    Type: Grant
    Filed: January 9, 2002
    Date of Patent: August 2, 2005
    Assignee: Novartis AG
    Inventors: Thomas Schupp, Christiane Toupet, Nathalie Engel
  • Publication number: 20050053927
    Abstract: The present invention primarily relates to a DNA fragment which is obtainable from the gene cluster responsible for rifamycin biosynthesis within the genome of Amycolatopsis mediterranei, and comprises at least one gene or a part of a gene which codes for a polypeptide which is directly or indirectly involved in the biosynthesis of rifamycin, and to a method for preparing said DNA fragment. The present invention furthermore relates to recombinant DNA molecules which comprise one of the DNA fragments according to the invention, and to the plasmids and vectors derived therefrom. Host organisms transformed with said plasmid or vector DNA are likewise embraced.
    Type: Application
    Filed: January 9, 2002
    Publication date: March 10, 2005
    Inventors: Thomas Schupp, Christiane Toupet, Nathalie Engel
  • Patent number: 6210935
    Abstract: The present invention relates especially to a DNA fragment that is obtainable from the gene cluster within the genome of Streptomyces or Actinomyces that is responsible for staurosporin biosynthesis and that contains at least one gene or a part of a gene that codes for a polypeptide that is involved directly or indirectly in the biosynthesis of staurosporin and to methods of preparing said DNA fragment. The present invention relates furthermore to recombinant DNA molecules containing one of the DNA fragments according to the invention and to the plasmids and vectors derived therefrom. Also included are host organisms transformed with the said plasmid or vector DNA.
    Type: Grant
    Filed: March 20, 1998
    Date of Patent: April 3, 2001
    Assignee: Novartis AG
    Inventors: Thomas Schupp, Nathalie Engel, Jürg Bietenhader, Christiane Toupet, Andreas Pospiech